ASP Isotopes Inc. (NASDAQ: ASPI) has released a letter to its shareholders from its chairman and CEO, Paul Mann. The company has achieved several significant milestones and has seen changes in various metrics since the last period.
The company has successfully shipped the first samples of both ytterbium-176 and silicon-28 to customers, representing potential revenues of $50 to $70 million during 2026 and 2027 from these two isotopes alone.
Furthermore, ASP Isotopes is in the process of procuring long lead-time equipment to deliver four new laser production plants, with plans to construct them starting in the first quarter of 2026. This signals a transition from primarily a research and development company to a commercial organization.
The company has also initiated the procurement process for critical long lead-time components for four new laser plants, which will be used to enrich gadolinium-160, zinc-68, nickel-64, and lithium-6/7, isotopes where significant customer interest has been received.
In addition, ASP Isotopes has hired Dr. Ryno Pretorius to become the CEO of Quantum Leap Energy ("QLE"). The company expects to have the first lithium-6 plant operational during 2026, subject to the timely receipt of all required permits and licenses, and aims to have a haleu production facility operational during 2027, subject to the receipt of all required permits and licenses.
The company has also made progress in its merger with Renergen, with the goal of creating a global leader in the production of critical and strategically important materials. The merger is on track for a 3Q 2025 close and is expected to be highly accretive to ASP Isotopes' financial metrics during 2026.
ASP Isotopes has listed its securities on the main board of the Johannesburg Stock Exchange on August 27, 2025, under the abbreviated name “ASPI”, with the share code “ISO” and international securities identification number US00218A1051. The company believes that this listing will enhance liquidity for shareholders, diversify the shareholder base, and position ASP Isotopes for growth by providing access to another deep capital market.
The company has significantly expanded and strengthened its management team, with over 170 employees, 20% of whom have a Ph.D., and 50% having an advanced degree. The senior management team has been bolstered with key appointments, including the Group CFO, General Counsel, and other key roles.
In preparation for its public listing, Quantum Leap Energy has also focused on building a highly capable scientific and management team, with Dr. Ryno Pretorius appointed as CEO and a new CFO set to commence on October 1, 2025.
The market has reacted to these announcements by moving the company's shares -7.6% to a price of $8.575. For the full picture, make sure to review ASP Isotopes's 8-K report.